Catalyst Wire Dossier Catalyst Wire Dossier

TAU-284

· Tanabe Pharma Corporation
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TAU-284, covering 2015-10-16 to 2015-12-15. Get the full timeline:

Most recent: Clinical Trial Update: The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]

See pricing